These data suggested that baicalin can inhibit tumor growth in vivo, which is due to the induction of tumor cellular senescence involving the upregulation of DEPP and the activation of Ras/Raf/MEK/ERK and p16INK4A/Rb signaling pathways. The gene discussed is CDKN2A; the disease is neoplasm.